“A golden opportunity is frequently being missed due to lack of financial incentives to study old inexpensive generic drugs for new indications.” Although there is a renewed interest in repurposing generic drugs to treat rare and neglected diseases, researchers struggle to find benefactors to fund their endeavors. To combat this, Crowd Funded Cures suggests a solution novel to the field: pay for success contracts. This funding system is designed to entice investors to fund expensive and expansive randomised controlled trials in exchange for outcome payments following success. Read full article here
